Biointelligence Platform and Enabler for Personalised Health and Wellness Journey
Non-communicable Diseases (NCDs) are the leading cause of death globally, responsible for 74% of deaths worldwide. It is predicted that, by 2060, total deaths of NCDs per capita will increase by 52%, while those of communicable diseases decline. However, more than half of the deaths are preventable with lifestyle adjustments.
Personalised healthcare and wellness have the potential to help people live longer, healthier lives, and to reduce the burden of chronic diseases. As technology advances, drawing connections between genetic data and personal insights is becoming more prevalent. The use of genetic data ranges from lifestyle change and intervention to disease prevention.
This Thai startup offers a biointelligence platform, founded to equip health professionals with comprehensive genetic information regarding patients’ or users’ predisposition to serious disease risks, which could be prevented or detected earlier. Together with an enabler platform for personalised health and wellness journey, they are able to provide tailored solutions for improved health and wellness, starting with the use of genetic data.
The technology owner is seeking partners in Singapore, such as supplement manufacturers, wellness clinics, and wellness tourism, to co-develop personalised solutions that integrate the use of genetic data to help people live longer and healthier lives.